Latest AI and machine learning research in chemotherapy for healthcare professionals.
BACKGROUND: Breast cancer-related lymphedema (BCRL) is a common and debilitating sequela of axillary lymph node dissection (ALND). Although machine learning (ML)-based prediction models have been proposed, few focus exclusively on patients undergoing ALND, and direct comparisons with traditional statistical models remain limited. This study aimed to develop accurate and clinically feasible predict...
BACKGROUND AND AIMS: Accurate risk stratification in stage II colorectal cancer is essential for treatment decision-making, as current guidelines recommend adjuvant chemotherapy only for patients with a high-risk of relapse. We aimed to develop and validate an AI-based approach for automated invasive front assessment to improve prognostic stratification in this population. METHODS: We developed SÉ...
In our practice, the treatment of pelvic bone tumors should begin with a multidisciplinary sarcoma-board evaluation that integrates biopsy-proven hist...
PURPOSE: The choice of adjuvant chemotherapy in pancreatic ductal adenocarcinoma (PDAC) is mainly guided by patients' general condition. We hypothesiz...
BACKGROUND: Tumour cells and tumour-associated stroma are key components of the tumour microenvironment, and their interaction impacts disease progres...
BACKGROUND: This article examines the impact of skeletal muscle mass and sarcopenia on the treatment of head and neck tumors using an AI-based review ...
OBJECTIVE: The aim of this study was to develop and validate an anatomy-driven model that predicts gross-total resection (GTR) of skull base chondrosa...
OBJECTIVES: To evaluate the efficiency and reliability of a large language model (LLM) as a decision-support tool in hospital compounding pharmacy for...
INTRODUCTION: Portal vein resection (PVR) has become an established component of pancreatic cancer surgery for selected patients with portal vein-supe...
BACKGROUND: Neoadjuvant therapy (NAT) is recommended for locally advanced gastric cancer (LAGC), but some patients respond poorly. We aimed to constru...
BACKGROUND: Alopecia areata (AA) is an autoimmune, hair loss-inducing disease affecting individuals of all genders and ethnic backgrounds worldwide. A...
Bladder cancer (BC) exhibits profound molecular heterogeneity and a highly dynamic tumor microenvironment, posing major challenges for effective thera...
High-grade gliomas (HGGs) are aggressive tumors with a propensity for recurrence. Despite standardized therapies, definitive treatment is elusive. Adv...
Hydrogen is central to the global clean energy transition, yet the widespread use of green hydrogen is constrained by its dependence on costly, supply...
BACKGROUND: Autologous breast reconstruction offers patients a durable and natural-appearing option after mastectomy. However, complication risks incl...
Long-term intravenous catheterization is vital for delivering chemotherapy to cancer patients and parenteral nutrition to those with intestinal failur...
PURPOSE: POSEIDON (NCT03164616) was a randomized, open-label, multicenter phase 3 trial comparing first-line durvalumab with or without tremelimumab i...
Keratins (KRTs) are intermediate filament proteins expressed in epithelial cells and serve as diagnostic cancer biomarkers. They serve pivotal roles i...
Neoadjuvant chemotherapy (NAC) followed by radical cystectomy is the standard of care for muscle-invasive bladder cancer (MIBC), yet treatment respons...
BACKGROUND: Muscle-invasive bladder cancer (MIBC) is an aggressive and heterogeneous malignancy with limited biomarkers to guide patient stratificatio...